Provided by Tiger Trade Technology Pte. Ltd.

INNOCARE

13.760
+0.4103.07%
Volume:5.83M
Turnover:80.11M
Market Cap:24.31B
PE:36.21
High:13.990
Open:13.470
Low:13.350
Close:13.350
52wk High:20.620
52wk Low:9.650
Shares:1.77B
HK Float Shares:1.49B
Volume Ratio:1.15
T/O Rate:0.39%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.380
ROE:10.36%
ROA:3.45%
PB:2.85
PE(LYR):36.21
PS:8.29

Loading ...

Breakthrough Psoriasis Data For Oral TYK2 Drug Might Change The Case For Investing In InnoCare Pharma (SEHK:9969)

Simply Wall St.
·
Jul 29

InnoCare Pharma's Phase III Trial of Fadeucravacitinib Meets Primary Endpoint

MT Newswires Live
·
Jul 28

Hong Kong Stock Market Preview: Disease Prevention 15th Five-Year Plan Issued, SK Hynix Breaches IPO Price on Wall Street

Stock News
·
Jul 28

Movement Alert|InnoCare Pharma Falls 5.04% in Regular Trading, Biotech Sector Sell-Off Compounds Post-Catalyst Profit-Taking

Market Focus
·
Jul 17

InnoCare Pharma's Phase II Study of Vitiligo Drug Shows Consistent Safety, Efficacy

MT Newswires Live
·
Jul 16

Innocare's TYK2 Inhibitor Soficitinib Meets Primary Endpoint in Phase II Vitiligo Study

Stock News
·
Jul 16

Phase III Trial for Innocare's Atopic Dermatitis Drug Meets Primary Endpoint

Stock News
·
Jul 15

Movement Alert|InnoCare Pharma Rises 5.09% in Regular Trading, Biotech Sector Rallies as CDH17 ADC Clinical Data Published

Market Focus
·
Jul 15

InnoCare Pharma (SEHK:9969) Is Up 6.6% After First CDH17 ADC Enters Human Trials

Simply Wall St.
·
Jul 14

Is InnoCare Pharma (SEHK:9969) Undervalued On Its Breakthrough Lupus Trial Results?

Simply Wall St.
·
Jul 11

Movement Alert|InnoCare Pharma Rises 5.07% in Regular Trading, HK Innovative Drug Sector Rallies as ADC Pipeline Advances

Market Focus
·
Jul 10

Innocare Pharma Shares Advance with Robust Quarterly Earnings Growth

Deep News
·
Jul 09

Hong Kong Market Closes Higher, Healthcare and Tech Stocks Lead Gains While AI Hardware Sector Plunges

Stock News
·
Jul 06

Biopharma Stocks Continue to Rally in Early Trading Session

Deep News
·
Jul 06

Innovative Drug Sector Maintains Upward Momentum on Favorable Regulatory Developments and Accelerating Internationalization

Stock News
·
Jul 06

Innocare's Stock Surges Over 9% as First Patient Dosed with Novel In-house Developed CDH17-Targeting ADC Drug

Deep News
·
Jul 06

Movement Alert|InnoCare Pharma Rises 6.65% in Regular Trading, Self-Developed ADC Drug ICP-B208 Completes First Patient Dosing

Market Focus
·
Jul 06

Hong Kong Innovative Drug Stocks Jump With HAIXI PHARMA and INNOCARE up 7%; KEYMED up 5%, REMEGEN up 4%

Tiger Newspress
·
Jul 06

Innocare Shares Surge Over 8% Following First Patient Dosing of Novel In-House ADC Drug

Stock News
·
Jul 06

InnoCare issues 1.91 million RSUs under 2023 Share Award Scheme, equal to 0.11% of share capital

Bulletin Express
·
Jun 30